EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Diagnosis of Colorectal Cancer Based on Bisulfite‐free Site‐specific Methylation Identification PCR Strategy: High‐Sensitivity, Accuracy, and Primary Medical Accessibility

Linqing Zhen, Xinlu Tang, Zhengguo Xu, Yizhou Huang, Xiaohua Qian, Haiping Lin, Chao Li, Rong Cui, Hongsheng Fang, Hao Yang, Jiani Qiu, Zhaoqi Fang und 8 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202401137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Linqing Zhen und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA Methylation, Early Detection of Cancer, Sensitivity and Specificity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SJTU STAR Interdisciplinary Important Program, Science and Technology program of Taizhou, Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to its decade‐long progression, colorectal cancer (CRC) is most suitable for population screening to achieve a significant reduction in its incidence and mortality. DNA methylation has emerged as a potential marker for the early detection of CRC. However, the current mainstream methylation detection method represented by bisulfite conversion has issues such as tedious operation, DNA damage, and unsatisfactory sensitivity. Herein, a new high‐performance CRC screening tool based on the promising specific terminal‐mediated polymerase chain reaction (STEM‐PCR) strategy is developed. CRC‐related methylation‐specific candidate CpG sites are first prescreened through The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases using self‐developed bioinformatics. Next, 9 homebrew colorectal cancer DNA methylated STEM‒PCR assays (ColoC‐mSTEM) with high sensitivity (0.1%) and high specificity are established to identify candidate sites. The clinical diagnostic performance of these selected methylation sites is confirmed and validated by a case‐control study. The optimized diagnostic model has an overall sensitivity of 94.8% and a specificity of 95.0% for detecting early‐stage CRC. Taken together, ColoC‐mSTEM, based on a single methylation‐specific site, is a promising diagnostic approach for the early detection of CRC which is perfectly suitable for the screening needs of CRC in primary healthcare institutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDNA MethylationEarly Detection of CancerSensitivity and SpecificityPolymerase Chain ReactionHumansMaleFemaleMiddle AgedCase-Control StudiesAgedBiomarkers, TumorAdult

Stichwörter der Autor:innen

ColoC‐mSTEMColorectal cancerearly detectionprimary medical accessibilityspecific methylation site

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.
  • Hefei Cancer Early Screening Innovation Technology Institute, Anhui Province, China.
  • Medical community of Linhai First People's Hospital, Zhejiang, 317000, P. R. China.
  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, P. R. China.
  • Jiading Hospital of Traditional Chinese medicine, Shanghai, 201800, P. R. China.
  • Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.

ORCID-Profile: Hong Xu

Förderung

  • SJTU STAR Interdisciplinary Important Program
  • Science and Technology program of Taizhou
  • Medical Science and Technology Project of Zhejiang Province
  • Major Projects of Special Development Funds in Zhangjiang National Independent Innovation Demonstration Zone, Shanghai

Zitieren

APA

Zhen, L., Tang, X., Xu, Z., Huang, Y., Qian, X., Lin, H., Li, C., Cui, R., Fang, H., Yang, H., Qiu, J., Fang, Z., Peng, X., Jin, Y., Nie, J., Guo, S., Wang, Y., Zhong, M., Gu, H., & Xu, H. (2024). Early Diagnosis of Colorectal Cancer Based on Bisulfite‐free Site‐specific Methylation Identification PCR Strategy: High‐Sensitivity, Accuracy, and Primary Medical Accessibility. Advanced Science. https://doi.org/10.1002/advs.202401137

Vancouver

Zhen L, Tang X, Xu Z, Huang Y, Qian X, Lin H, et al. Early Diagnosis of Colorectal Cancer Based on Bisulfite‐free Site‐specific Methylation Identification PCR Strategy: High‐Sensitivity, Accuracy, and Primary Medical Accessibility. Advanced Science. 2024. doi:10.1002/advs.202401137

BibTeX
@article{Zhen2024,
  author = {Zhen, Linqing and Tang, Xinlu and Xu, Zhengguo and Huang, Yizhou and Qian, Xiaohua and Lin, Haiping and Li, Chao and Cui, Rong and Fang, Hongsheng and Yang, Hao and Qiu, Jiani and Fang, Zhaoqi and Peng, Xiaohuan and Jin, Yifeng and Nie, Jianing and Guo, Shiwei and Wang, Yuguang and Zhong, Ming and Gu, Hongchen and Xu, Hong},
  title = {Early Diagnosis of Colorectal Cancer Based on Bisulfite‐free Site‐specific Methylation Identification PCR Strategy: High‐Sensitivity, Accuracy, and Primary Medical Accessibility},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202401137}
}
Kostenlos starten →